Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 6

1.

Pathophysiology of Depression: Molecular Regulation of Melatonin Homeostasis - Current Status.

Dmitrzak-Weglarz M, Reszka E.

Neuropsychobiology. 2017;76(3):117-129. doi: 10.1159/000489470. Epub 2018 Jun 13. Review.

PMID:
29898451
2.

ASMT gene expression correlates with cognitive impairment in patients with recurrent depressive disorder.

Talarowska M, Szemraj J, Zajączkowska M, Gałecki P.

Med Sci Monit. 2014 Jun 2;20:905-12. doi: 10.12659/MSM.890160.

3.
4.

Genetic and functional abnormalities of the melatonin biosynthesis pathway in patients with bipolar disorder.

Etain B, Dumaine A, Bellivier F, Pagan C, Francelle L, Goubran-Botros H, Moreno S, Deshommes J, Moustafa K, Le Dudal K, Mathieu F, Henry C, Kahn JP, Launay JM, Mühleisen TW, Cichon S, Bourgeron T, Leboyer M, Jamain S.

Hum Mol Genet. 2012 Sep 15;21(18):4030-7. doi: 10.1093/hmg/dds227. Epub 2012 Jun 13.

PMID:
22694957
5.

Polymorphisms in melatonin synthesis pathways: possible influences on depression.

Kripke DF, Nievergelt CM, Tranah GJ, Murray SS, McCarthy MJ, Rex KM, Parimi N, Kelsoe JR.

J Circadian Rhythms. 2011 Aug 9;9:8. doi: 10.1186/1740-3391-9-8.

6.

Single-nucleotide polymorphisms and mRNA expression for melatonin synthesis rate-limiting enzyme in recurrent depressive disorder.

Gałecki P, Szemraj J, Bartosz G, Bieńkiewicz M, Gałecka E, Florkowski A, Lewiński A, Karbownik-Lewińska M.

J Pineal Res. 2010 May;48(4):311-7. doi: 10.1111/j.1600-079X.2010.00754.x.

PMID:
20433639

Supplemental Content

Loading ...
Support Center